Evidence map›Paper›PMID 39301132›Full record

ArticleIJTLD open2024

One step further: improving paediatric TB diagnosis through user-centred research approaches.

F W Basile, E M Bijker, M Sekadde, S E Dorman, J J Ellner, N Engel, M Ruhwald, R Song

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in IJTLD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

F W BasileDepartment of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.
E M BijkerDepartment of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.
M SekaddeNational TB and Leprosy Program, Uganda Ministry of Health, Kampala, Uganda.
S E DormanMedical University of South Carolina, Charleston, SC, USA.
J J EllnerDepartment of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
N EngelDepartment of Health, Ethics & Society, Maastricht University, Maastricht, the Netherlands.
M RuhwaldFIND, Geneva, Switzerland.
R SongDepartment of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.

Funding

FEND for TB supplement to accelerate BLINK X developmentU01AI152084 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ALLAND, DAVID, DORMAN, SUSAN E · 2020 to 2024
$20.0M
Novel and Optimized Diagnostics for Pediatric TBR01AI152159 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI ALLAND, DAVID, ELLNER, JERROLD J. · 2020 to 2024
$6.0M
NIAID NIH HHS R01 AI152159NIAID NIH HHS U01 AI152084
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diagnosisimplementationpaediatric TBqualitativeR&D; feasibilitytuberculosisuser-centred research

Identifiers

PMID39301132
PMCPMC11409169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.